Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis
First Claim
1. An assay reagent for determining the activity of an enzyme in a metabolically active whole cell, said assay reagent comprising at least one water soluble physiologically acceptable salt having the ability to pass through a cell membrane, said assay compound having an unblocked leaving group selected for cleavage by an enzyme to be analyzed selected from cysteine protease, dipeptyl peptidase and calpain, and a fluorogenic indicator group being selected for its ability to have a non-fluorescent first state when joined to the leaving group, and a fluorescent second state excitable at a wavelength above 450 nm when the unblocked leaving group is cleaved from the indicator group by the enzyme, wherein said fluorogenic indicator group is selected from the group consisting of rhodamine 110, rhodol, fluorescein and derivative thereof, said assay reagent having a fluorescence less than the auto-fluorescence of a metabolically active cell.
3 Assignments
0 Petitions
Accused Products
Abstract
The ability to determine the stage or pathway of cysteine proteases in a single cell assay has long been desired as a material event in apoptosis. The present invention relates to a method and assay reagents for determining enzyme activity and relating said activity to the apoptotic pathway. In addition, the method find utility in distinguishing apoptotic activity from necrotic activity.
-
Citations
20 Claims
- 1. An assay reagent for determining the activity of an enzyme in a metabolically active whole cell, said assay reagent comprising at least one water soluble physiologically acceptable salt having the ability to pass through a cell membrane, said assay compound having an unblocked leaving group selected for cleavage by an enzyme to be analyzed selected from cysteine protease, dipeptyl peptidase and calpain, and a fluorogenic indicator group being selected for its ability to have a non-fluorescent first state when joined to the leaving group, and a fluorescent second state excitable at a wavelength above 450 nm when the unblocked leaving group is cleaved from the indicator group by the enzyme, wherein said fluorogenic indicator group is selected from the group consisting of rhodamine 110, rhodol, fluorescein and derivative thereof, said assay reagent having a fluorescence less than the auto-fluorescence of a metabolically active cell.
-
10. A method of performing an assay for detecting the presence of a enzymatic activity in a metabolically active whole cell to determine the apoptotic stage of the cell comprising:
-
(a) contacting a test, metabolically active whole cell with an assay reagent, said assay reagent comprising at least one water soluble physiologically acceptable salt having the ability to pass through a cell membrane, said assay compound having an unblocked leaving group selected for cleavage by an enzyme to be analyzed selected from cysteine protease, dipeptyl peptidase and calpain, and a fluorogenic indicator group being selected for its ability to have a non-fluorescent first state when joined to the leaving group, and a fluorescent second state excitable at a wavelength above 450 nm when the unblocked leaving group is cleaved from the indicator group by the enzyme, wherein said fluorogenic indicator group is selected from the group consisting of rhodamine 110, rhodol, fluorescein and derivative thereof;
said assay reagent having a fluorescence less than the auto-fluorescence of a metabolically active cell,(b) sensing for said fluorescent second state of the indicator group for the test, metabolically active whole cell to produce a test result, and (c) determining an apoptotic stage of said metabolically active whole cell from said test result. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
Specification